ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,690Medicare Part D Prescriptions Filled, Including Refills

Rank: 177 out of 2343

$803K Total Retail Price of All Prescriptions

Rank: 235 out of 2343

322 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 565 479 1 7
LEVOTHYROXINE SODIUM 517 477 2 2
OMEPRAZOLE 504 394 3 4
HYDROCODONE-ACETAMINOPHEN 503 305 S3 4 13
LISINOPRIL 502 410 5 3
FUROSEMIDE 481 427 6 6
SIMVASTATIN 460 370 7 1
AMLODIPINE BESYLATE 454 378 8 5
WARFARIN SODIUM 331 329 9 8
GABAPENTIN 292 238 10 16
METOPROLOL SUCCINATE 264 211 11 14
NAMENDA 257 240 12 36
DONEPEZIL HCL 252 238 13 21
LANTUS 236 206 14 51
PRAVASTATIN SODIUM 224 172 15 15
POLYETHYLENE GLYCOL 3350 207 187 16 54
RISPERIDONE 203 200 17 61
CITALOPRAM HBR 180 132 18 17
DIVALPROEX SODIUM 171 171 19 105
PANTOPRAZOLE SODIUM 164 136 20 22
ZOLPIDEM TARTRATE 161 126 21 24
ATENOLOL 157 118 22 12
CYMBALTA 155 129 23 74
METFORMIN HCL 154 94 24 9
RANITIDINE HCL 146 125 25 43
CRESTOR 140 107 26 30
SPIRIVA 137 108 27 48
ATORVASTATIN CALCIUM 136 101 28 10
SERTRALINE HCL 130 114 29 20
AZITHROMYCIN 127 87 30 39
AMLODIPINE BESYLATE-BENAZEPRIL 111 99 31 59
TRAMADOL HCL 107 100 32 25
CLOPIDOGREL 106 67 33 26
POTASSIUM CHLORIDE 105 105 34 18
NEXIUM 104 86 35 33
MIRTAZAPINE 104 101 35 41
HYDROCHLOROTHIAZIDE 103 88 37 11
OXYBUTYNIN CHLORIDE 94 82 38 169
DIOVAN 94 91 38 23
MELOXICAM 88 54 40 68
PLAVIX 87 51 41 38
CIPROFLOXACIN HCL 85 74 42 72
ALLOPURINOL 84 76 43 31
NOVOLOG 83 65 44 110
EVISTA 82 73 45 128
ADVAIR DISKUS 81 57 46 34
HUMALOG 81 77 46 131
COMBIVENT 76 57 48 144
ISOSORBIDE MONONITRATE ER 76 62 48 32
CARBIDOPA-LEVODOPA 76 76 48 85
ESCITALOPRAM OXALATE 75 73 51 55
LEVOFLOXACIN 73 44 52 106
LOSARTAN POTASSIUM 70 68 53 19
AVELOX 70 61 53 360
PROAIR HFA 70 37 53 86
SPIRONOLACTONE 68 56 56 65
TRAZODONE HCL 67 57 57 53
DIGOXIN 66 55 58 35
SANTYL 66 34 58 195
GLYBURIDE-METFORMIN HCL 63 47 R 60 154
LEVETIRACETAM 63 56 60 104
CEPHALEXIN 63 62 60 111
VOLTAREN 62 61 63 175
PREDNISONE 61 58 64 37
PHENYTOIN SODIUM EXTENDED 60 60 65 152
INSULIN SYRINGE 60 53 65 102
GLYBURIDE 59 46 R 67 62
FLUTICASONE PROPIONATE 59 53 67 46
IPRATROPIUM-ALBUTEROL 59 54 67 99
LYRICA 58 52 70 135
NYSTATIN 58 49 70 172
JANUVIA 58 45 70 50
BENAZEPRIL HCL 56 49 73 113
FLOVENT HFA 56 39 73 213
CARVEDILOL 55 32 75 27
IPRATROPIUM BROMIDE 52 52 76 192
GLIPIZIDE 52 52 76 56
VENLAFAXINE HCL ER 51 20 78 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.